Cargando…
Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide
The major potential adverse effect of use of sulfonylurea agents (SUAs) is a hyperinsulinaemic state that causes hypoglycaemia. It may be observed during chronic therapeutic dosing, even with very low doses of a SUA, and especially in older patients. It may also result from accidental or intentional...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2005
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1414034/ https://www.ncbi.nlm.nih.gov/pubmed/16356235 http://dx.doi.org/10.1186/cc3807 |